Gloria Berinyuy Tata is addressing the need for improved screening procedures for the early detection of Streptococcus agalactiae, a leading cause of neonatal and maternal sepsis. Her proposed solution involves developing a novel molecular diagnostic tool based on the LAMP-CRISPR-Cas 12 technology, aiming to provide an accurate, affordable, and simple-to-use method for early detection.
Falling Walls
Falling Walls Science Summit 2023
Login or Register
You need to be logged in to use this feature.
Breaking the Wall of Bacteria Detection
Gloria Berinyuy Tata is a research assistant at Mboalab Biotech, where she uses her Master of Health Science degree in immunology from the Catholic University of Central Africa to develop CRISPR-based diagnostic tests for infectious diseases. She is passionate about creating cost-efficient and highly sensitive tests that can be used in low-resource settings.
Further Activities to have a look at